1. 109P18F-FDG PET/CT textural features as predictors of outcomes in patients with primary advanced colorectal cancer. (24th November 2019) Authors: Yang, J; Cheng, Y; Ma, X Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 136PHelicobacter pylori-positive gastric diffuse large B-cell lymphoma: A subset with distinct prognostic features. (24th November 2019) Authors: Cheng, Y; Ma, X; Yang, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1381PDGefitinib with or without pemetrexed in nonsquamous (NS) non-small cell lung cancer (NSCLC) with EGFR mutation (mut): Final overall survival (OS) results from a randomized phase II study. (23rd October 2018) Authors: Yang, J C-H; Cheng, Y; Murakami, H; Yang, P-C; He, J; Nakagawa, K; Kang, J H; Kim, J-H; Wnag, X; Enatsu, S; Puri, T; Orlando, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1390PDose modification and therapy interruption due to adverse events in treatment with anlotinib for refractory advanced NSCLC: Data from ALTER0303. (23rd October 2018) Authors: Zhang, L; Si, X; Wang, H; Zhang, X; Wang, M; Han, B; Li, K; Wang, Q; Shi, J; Wang, Z; Cheng, Y; He, J; Shi, Y; Chen, W; Wang, X; Luo, Y; Nan, K; Jin, F; Li, B; Chen, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 230POlaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort. (24th November 2019) Authors: Wu, L; Zhu, J; Yin, R; Wu, X; Lou, G; Wang, J; Gao, Y; Kong, B; Lu, X; Zhou, Q; Wang, Y; Chen, Y; Lu, W; Li, W; Cheng, Y; Liu, J; Ma, X; Zhang, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 283O_PRPhase III trial of chidamide, a subtype-selective histone deacetylase (HDAC) inhibitor, in combination with exemestane in patients with hormone receptor-positive advanced breast cancer. (23rd October 2018) Authors: Jiang, Z; Li, W; Hu, X; Zhang, Q; Sun, T; Cui, S; Wang, S; Ouyang, Q; Yin, Y; Geng, C; Tong, Z; Cheng, Y; Pan, Y; Sun, Y; Wang, H; Ouyang, T; Gu, K; Feng, J; Wang, X Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 339TiPPACIFIC-5: Phase III study of durvalumab after either concurrent or sequential chemoradiotherapy (CRT) in patients with stage III NSCLC. (24th November 2019) Authors: Wu, Y-L; Wang, L; Sendur, M A N; Kim, Y-C; Zhu, Z; Cheng, Y; Li, P; Qin, Y; Macpherson, E; Dennis, P A; Lu, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 480PSafety and efficacy of dacomitinib for EGFR+ NSCLC in the subgroup of Asian patients from ARCHER 1050. (24th November 2019) Authors: Mok, T S K; Cheng, Y; Zhou, X; Lee, K H; Nakagawa, K; Niho, S; Rosell, R; Linke, R; Wong, C H; Tang, Y; Singh, M; Wilner, K D; Wu, Y-L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 492OOsimertinib for patients (pts) with leptomeningeal metastases (LM) associated with EGFRm advanced NSCLC. (25th November 2018) Authors: Ahn, M-J; Chiu, C-H; Cheng, Y; Han, J-Y; Goldberg, S B; Greystoke, A; Crawford, J; Zhao, Y; Huang, X; Johnson, M; Vishwanathan, K; Mendoza-Naranjo, A; Mok, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 511PAURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS). (25th November 2018) Authors: Zhou, C; Wang, M; Cheng, Y; Chen, Y; Zhao, Y; Shi, Y-K; Ahn, M-J; Lu, Y; Shi, M; Han, J-Y; Kim, S-W; Zhang, H-L; Chen, G; Li, H; Wang, J; Wu, Y-L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗